
Mydacla Tablet - Daclatasvir Dihydrocloride 60mg, Effective Direct-acting Antiviral For Chronic Hcv Genotype 3 Treatment, Low Side Effects & Long Shelf Life
Price:
Get Latest Price
In Stock
Product Specifications
| Composition | Each tablet contains 60 mg of Daclatasvir |
| Appearance | Round biconvex film-coated tablet |
| Precautions | Use under medical supervision not recommended for pregnant or breastfeeding women |
| Feature | High efficacy in patients with Hepatitis C convenient oral dosage form |
| Weight | 500 mg per tablet |
| Lead Time | 2-3 weeks after order confirmation |
| Color | Light yellow |
| Product Type | Other , Tablet |
| Ingredients | Other , Daclatasvir |
| Physical Form | Solid (Tablet), Other |
| Treatments & Functions | Other Functions, Used in the treatment of Hepatitis C infection |
| Age Group | Other, Adults |
| Dosage Guidelines | Other, As prescribed by a healthcare professional; typically one tablet per day |
| Quantity | 28 tablets per pack |
| Packaging | Aluminium foil blister packing, Other |
| Storage Instructions | Store below 30AdegC protect from light and moisture |
| Main Export Market(s) | Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa |
Company Details
Business Type
Exporter, Distributor, Trading Company
Employee Count
10
Establishment
1991
Working Days
Monday To Sunday
GST NO
27AARFP5752B1Z1
Related Products
More Product From This seller
Seller Details
GST - 27AARFP5752B1Z1
Mumbai, Maharashtra
Accepts only Foreign inquiries
Proprietor
Mr Amith Dhiraj Galaa
Members since
10 Years
Address
12/B, Thacker Industrial Estate, N. M. Joshi Marg, Lower Parel (E), Mumbai, Maharashtra, 400011, India
Report incorrect details





























